Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Cell|October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodiesPavlo Gilchuk, Charles D Murin, Robert W Cross, et al.Plos Pathogens|June 27, 2015
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPsMarnie L Fusco, Takao Hashiguchi, Robyn Cassan, et al.Nature Microbiology|May 9, 2018
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER regionAndrew I Flyak, Natalia Kuzmina, Charles D Murin, et al.Cell|January 26, 2016
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus InfectionAndrew I Flyak, Xiaoli Shen, Charles D Murin, et al.Cell|May 20, 2017
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against EbolavirusesAnna Z Wec, Andrew S Herbert, Charles D Murin, et al.Science (New York, N.Y.)|February 26, 2016
Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreakZachary A Bornholdt, Hannah L Turner, Charles D Murin, et al.Nature Structural & Molecular Biology|May 28, 2013
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120Leopold Kong, Jeong Hyun Lee, Katie J Doores, et al.Cell Reports|May 11, 2016
Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding SiteKatie A Howell, Xiangguo Qiu, Jennifer M Brannan, et al.Immunity|February 6, 2020
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus NeutralizationPavlo Gilchuk, Charles D Murin, Jacob C Milligan, et al.The Journal of Infectious Diseases|June 4, 2018
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman PrimatesKristen E Pascal, Drew Dudgeon, John C Trefry, et al.Pageof 3